We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleTRIZAL study: switching from successful HAART to Trizivir (abacavir-lamivudine-zidovudine combination tablet): 48 weeks efficacy, safety and adherence results.AuthorsKatlama C; Fenske S; Gazzard B; Lazzarin A; Clumeck N; Mallolas J; Lafeuillade A; Mamet JP; Beauvais LPublicationHIV medicine, 2003, Vol 4, Issue 2, p79ISSN1464-2662Publication typearticleDOI10.1046/j.1468-1293.2003.00139.x